You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Triamcinolone acetonide - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

What are the generic sources for triamcinolone acetonide and what is the scope of patent protection?

Triamcinolone acetonide is the generic ingredient in twenty-seven branded drugs marketed by Abbvie, Chattem Sanofi, Astellas, Ivax Pharms, Delcor Asset Corp, Teva, Solvay, Actavis Mid Atlantic, Alkem Labs Ltd, Alpharma Us Pharms, Ambix, Chartwell Rx, Cosette, Encube, Fougera Pharms, Glenmark Pharms Ltd, Macleods Pharms Ltd, Micro Labs, Morton Grove, Mylan, Padagis Us, Pharmaderm, Pharmafair, Strides Pharma, Taro, Topiderm, Crown Labs, Savage Labs, Pacira Pharms Inc, Apothecon, Amneal, Eugia Pharma, Long Grove Pharms, Mylan Labs Ltd, Parnell, Sandoz, Teva Pharms Usa, Watson Labs, Allergan, Harrow Eye, Epic Pharma Llc, Pai Holdings Pharm, Quagen, Wockhardt Bio Ag, Aurobindo Pharma Ltd, Cintex Svcs, Glenmark Pharms, Padagis Israel, Cmp Pharma Inc, Akorn, Lyne, Lupin Atlantis, Sanofi Aventis Us, Apotex, Perrigo Pharma Intl, Sun Pharm Inds Inc, Rising, Saptalis Pharms, and Bausch And Lomb Inc, and is included in one hundred and thirty-nine NDAs. There are seven patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Triamcinolone acetonide has one hundred and fifty-seven patent family members in twenty-nine countries.

There are twenty-six drug master file entries for triamcinolone acetonide. Sixty-nine suppliers are listed for this compound.

Summary for triamcinolone acetonide

International Patents:	157
US Patents:	7
Tradenames:	27
Applicants:	59
NDAs:	139
Drug Master File Entries:	26
Finished Product Suppliers / Packagers:	69
Raw Ingredient (Bulk) Api Vendors:	80
Clinical Trials:	255
Patent Applications:	7,044
Formulation / Manufacturing:	see details
Drug Prices:	Drug price trends for triamcinolone acetonide
Drug Sales Revenues:	Drug sales revenues for triamcinolone acetonide
What excipients (inactive ingredients) are in triamcinolone acetonide?	triamcinolone acetonide excipients list
DailyMed Link:	triamcinolone acetonide at DailyMed

See drug prices for triamcinolone acetonide

Drug Sales Revenue Trends for triamcinolone acetonide

See drug sales revenues for triamcinolone acetonide

Recent Clinical Trials for triamcinolone acetonide

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Gadjah Mada University	Phase 1/Phase 2
Innovaderm Research Inc.	Phase 4
Centre hospitalier de l'Université de Montréal (CHUM)	Phase 4

See all triamcinolone acetonide clinical trials

Pharmacology for triamcinolone acetonide

Drug Class	Corticosteroid
Mechanism of Action	Corticosteroid Hormone Receptor Agonists

Medical Subject Heading (MeSH) Categories for triamcinolone acetonide

Anti-Inflammatory Agents
Glucocorticoids
Immunosuppressive Agents

US Patents and Regulatory Information for triamcinolone acetonide

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Astellas	ARISTOCORT A	triamcinolone acetonide	OINTMENT;TOPICAL	080745-003	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Sanofi Aventis Us	NASACORT HFA	triamcinolone acetonide	SPRAY, METERED;NASAL	020784-001	Apr 7, 2004		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Astellas	ARISTOCORT A	triamcinolone acetonide	CREAM;TOPICAL	088820-001	Oct 16, 1984		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Encube	TRIAMCINOLONE ACETONIDE	triamcinolone acetonide	OINTMENT;TOPICAL	212384-001	Nov 29, 2019	AT	RX	No	Yes	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for triamcinolone acetonide

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Chattem Sanofi	NASACORT	triamcinolone acetonide	AEROSOL, METERED;NASAL	019798-001	Jul 11, 1991	⤷ Try a Trial	⤷ Try a Trial
Delcor Asset Corp	KENALOG-H	triamcinolone acetonide	CREAM;TOPICAL	086240-001	Approved Prior to Jan 1, 1982	⤷ Try a Trial	⤷ Try a Trial
Harrow Eye	TRIESENCE	triamcinolone acetonide	INJECTABLE;INTRAVITREAL	022048-001	Nov 29, 2007	⤷ Try a Trial	⤷ Try a Trial
Abbvie	AZMACORT	triamcinolone acetonide	AEROSOL, METERED;INHALATION	018117-001	Apr 23, 1982	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for triamcinolone acetonide

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
European Patent Office	2600836	CORTICOSTÉROÏDES POUR LE TRAITEMENT DE LA DOULEUR ARTICULAIRE (CORTICOSTEROIDS FOR THE TREATMENT OF JOINT PAIN)	⤷ Try a Trial
Japan	2019059752	関節痛の治療のためのコルチコステロイド (CORTICOSTEROIDS FOR TREATMENT OF JOINT PAIN)	⤷ Try a Trial
South Korea	20180132159	관절 통증의 치료를 위한 코르티코스테로이드 (CORTICOSTEROIDS FOR THE TREATMENT OF JOINT PAIN)	⤷ Try a Trial
Taiwan	I548412		⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.